awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q37494846-73E6E743-8B24-4B15-8BF7-0A724E6BA580
Q37494846-73E6E743-8B24-4B15-8BF7-0A724E6BA580
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37494846-73E6E743-8B24-4B15-8BF7-0A724E6BA580
Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives.
P2860
Q37494846-73E6E743-8B24-4B15-8BF7-0A724E6BA580
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37494846-73E6E743-8B24-4B15-8BF7-0A724E6BA580
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
119e9c8b992b6d82c855f3c9c67aa1f6a346bf42
P2860
Treatment of Fabry disease: outcome of a comparative trial with agalsidase alfa or beta at a dose of 0.2 mg/kg